We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

147 hedge funds and large institutions have $806M invested in Dynavax Technologies in 2015 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 67 increasing their positions, 31 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

392% more call options, than puts

Call options by funds: $21.7M | Put options by funds: $4.41M

255% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 11

116% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 31

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

29% more capital invested

Capital invested by funds: $625M → $806M (+$181M)

23% more funds holding

Funds holding: 120147 (+27)

Holders
147
Holders Change
+27
Holders Change %
+22.5%
% of All Funds
4.1%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
39
Increased
67
Reduced
31
Closed
11
Calls
$21.7M
Puts
$4.41M
Net Calls
+$17.3M
Net Calls Change
-$6.52M
Name Holding Trade Value Shares
Change
Change in
Stake
SM
51
Sabby Management
Florida
$3.31M +$1.84M +64,954 +93%
TCIM
52
TIAA CREF Investment Management
New York
$3.21M +$903K +31,883 +32%
Morgan Stanley
53
Morgan Stanley
New York
$3.19M -$1.53M -54,079 -29%
ARTA
54
A.R.T. Advisors
New York
$3.17M +$2.18M +76,993 +147%
CS
55
Candriam SCA
Luxembourg
$3.16M +$2.17M +76,800 +148%
Citigroup
56
Citigroup
New York
$3.13M +$2.07M +73,213 +135%
BIM
57
BlackRock Investment Management
Delaware
$3.12M +$651K +22,975 +22%
Goldman Sachs
58
Goldman Sachs
New York
$3.01M +$1.89M +66,800 +120%
PI
59
Putnam Investments
Massachusetts
$2.8M +$91.2K +3,221 +3%
Charles Schwab
60
Charles Schwab
California
$2.73M +$1.54M +54,457 +96%
GL
61
GLG LLC
New York
$2.7M +$3.11M +110,000 New
SFM
62
Sphera Funds Management
Israel
$2.45M -$1.42M -50,000 -33%
RFC
63
Russell Frank Company
Washington
$2.15M -$139K -4,925 -5%
JP Morgan Chase
64
JP Morgan Chase
New York
$1.91M +$2.2M +77,800 New
Allianz Asset Management
65
Allianz Asset Management
Germany
$1.85M +$2.13M +75,373 New
BBA
66
Baker Bros. Advisors
New York
$1.84M +$2.12M +75,000 New
MCM
67
Moore Capital Management
New York
$1.84M +$2.12M +75,000 New
GH
68
GAM Holding
Switzerland
$1.81M +$2.09M +73,700 New
American Century Companies
69
American Century Companies
Missouri
$1.67M +$738K +26,048 +62%
California State Teachers Retirement System (CalSTRS)
70
California State Teachers Retirement System (CalSTRS)
California
$1.64M +$374K +13,200 +25%
Susquehanna International Group
71
Susquehanna International Group
Pennsylvania
$1.54M +$1.42M +50,056 +391%
TI
72
Trexquant Investment
Connecticut
$1.5M +$1.39M +49,189 +407%
GKIM
73
GW&K Investment Management
Massachusetts
$1.5M +$46.3K +1,635 +3%
CC
74
CQS Cayman
Cayman Islands
$1.47M -$680K -24,000 -29%
MCM
75
Mazama Capital Management
Oregon
$1.4M +$1.61M +56,830 New

DVAX Hedge Fund Activity: Q3 2015 in Review

147 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2015, worth a combined $806M — up 29% from $625M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new DVAX positions and 11 closed out — a net gain of 28 holders — while 67 added to existing stakes and 31 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $70M. The largest seller was RA Capital Management, exiting entirely with an estimated $17.9M sold.

  • 147 institutional investors held Dynavax Technologies (DVAX) as of Q3 2015, up from 120 in Q2 2015.
  • Funds reported $806M of Dynavax Technologies stock for Q3 2015, up 29% quarter-over-quarter.
  • 39 funds opened new Dynavax Technologies positions in Q3 2015 and 11 closed out, a net change of +28 holders.
  • The largest Dynavax Technologies buyer in Q3 2015 was OrbiMed, an estimated $70M added.
  • The largest Dynavax Technologies seller in Q3 2015 was RA Capital Management, an estimated $17.9M sold.

Based on aggregated 13F filings for Q3 2015.